(R)-Darifenacin hydrobromide
CAS: 1092800-15-1
Ref. 3D-STB80015
1mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued |
Product Information
(R)-Darifenacin hydrobromide is a medicinal compound that has shown promise as an anticancer agent. It is a potent inhibitor of kinase activity, which plays a critical role in cancer cell growth and division. (R)-Darifenacin hydrobromide has been found to induce apoptosis, or programmed cell death, in human and Chinese hamster cancer cells by disrupting the cell cycle. This compound is an analog of other cancer inhibitors and has been shown to be effective against various types of tumors in preclinical studies. (R)-Darifenacin hydrobromide is excreted primarily through urine, making it a promising candidate for further development as an anticancer therapy.